Brendan Digan
Stock Analyst at Citi
(2.03)
# 3,346
Out of 5,133 analysts
6
Total ratings
66.7%
Success rate
12.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Brendan Digan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Reiterated: Buy | $315 → $365 | $319.09 | +14.39% | 3 | Aug 14, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $45 | $49.89 | -9.80% | 1 | Aug 10, 2026 | |
| SHC Sotera Health Company | Reiterated: Buy | $25 | $16.61 | +50.51% | 1 | Aug 7, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $50 | $58.19 | -14.07% | 1 | Aug 7, 2026 |
Natera
Aug 14, 2026
Reiterated: Buy
Price Target: $315 → $365
Current: $319.09
Upside: +14.39%
Qiagen
Aug 10, 2026
Reiterated: Hold
Price Target: $45
Current: $49.89
Upside: -9.80%
Sotera Health Company
Aug 7, 2026
Reiterated: Buy
Price Target: $25
Current: $16.61
Upside: +50.51%
10x Genomics
Aug 7, 2026
Reiterated: Hold
Price Target: $50
Current: $58.19
Upside: -14.07%